EMFLAZA
NDC 52856-502, deflazacort, tablet, from PTC Therapeutics, Inc..
- Product NDC
- 52856-502
- Status
- Listed
- Labeler
- PTC Therapeutics, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208684
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52856-502 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFLAZACORT18 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52856-502-03 | 52856050203 | 30 TABLET in 1 BOTTLE (52856-502-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/31b347d2-f156-4055-9d8f-7cf0df420296
Use it
Look up 52856-502 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52856-502 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52856-502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.